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Abstract
Background: To assess the prevalence of cyclic perimenstrual pain and discomfort and to detail the pattern of
complementary and alternative (CAM) use adopted by women for the treatment of these symptoms.
Methods: Data from the 2012 national Australian Longitudinal Study of Women’s Health (ALSWH) cross-sectional
survey of 7427 women aged 34–39 years were analysed to estimate the prevalence of endometriosis, premenstrual
syndrome (PMS), irregular or heavy periods and severe dysmenorrhoea and to examine the association between
their symptoms and their visits to CAM practitioners as well as their use of CAM therapies and products in the
previous 12 months.
Results: The prevalence of endometriosis was 3.7 % and of the perimenstrual symptoms assessed, PMS was most
prevalent at 41.2 % whilst irregular bleeding (22.2 %), heavy periods (29.8 %) and severe period pain (24.1 %) were
reported at lower levels. Women with endometriosis were more likely than non-sufferers to have consulted with a
massage therapist or acupuncturist and to have used vitamins/minerals, yoga/meditation or Chinese medicines (p < 0.05).
PMS sufferers were more likely to consult with an osteopath, massage therapist, naturopath/herbalist or
alternative health practitioner and to have used all forms of CAM therapies except Chinese medicines than
women who had infrequent PMS (all p < 0.05). Women with irregular periods did not have different patterns
of CAM use from non-sufferers and those with heavy periods did not favour any form of CAM but were less
likely to visit a massage therapist or use yoga/meditation than non-sufferers (p < 0.05). For women with severe
dysmenorrhoea there was no difference in their visits to CAM practitioners compared to non-sufferers but
they were more likely to use aromatherapy oils (p < 0.05) and for more frequent dysmenorrhoea also herbal
medicines, Chinese medicines and other alternative therapies compared to non-sufferers (all p < 0.05).
Conclusions: There is a high prevalence of cyclic perimenstrual pain and discomfort amongst women in this
age group. Women were using CAM differentially when they had specific symptoms of cyclic perimenstrual
pain and discomfort. The use of CAM needs to be properly assessed to ensure their safe, effective use and to
ascertain their significance as a treatment option enabling women with menstrual problems and their care
providers to improve their quality of life.
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Background
Menstruation is a normal, cyclic event spanning a
women’s life from the onset of puberty (usually around
12–13 years of age) through to menopause (which most
women experience around 50 years of age). Although
the phenomenon of cyclic problems experienced by
women during their reproductive years had been recog-
nised by Hippocrates [1] modern science has not yet
fully explained the causes of the variety of symptoms
that can accompany the menstrual cycle [1–4]. More-
over symptoms have been treated as separate entities,
most commonly identified as either premenstrual
syndrome (PMS) or dysmenorrhoea, although their co-
existence was highlighted by Bancroft in 1995 [2].
Affective symptoms like irritability and depression and
physical symptoms such as bloating, dysmenorrhoea,
nausea and breast tenderness often occur in the luteal
phase of the cycle and/or into menstruation. Symptoms
may vary in severity and scope from one cycle to the
next and are likely due to a number of different factors
[2, 5–7]. Such changes were labelled ‘cyclic perimenstr-
ual pain and discomfort’ (CPPD) by the Association of
Women’s Health, Obstetric and Neonatal Nurses [5] to
better reflect the protean nature of symptoms. It is esti-
mated that between 80 and 97 % of women worldwide
and across age groups experience at least one symptom
during their reproductive life [6–9]. For up to 40 % of
women [7] symptoms are moderate and for a further 2–
10 % of women symptoms are severe enough to interfere
with normal daily life [4, 6, 8, 10]. It is possible that the
prevalence of CPPD has increased as modern women
are exposed to sex-hormone cycles for a greater propor-
tion of their lives due to earlier onset of menarche, re-
duced number of births and the delayed resumption of
menstrual cycles consequent on breastfeeding. Though
cultural differences may change women’s perception of,
and treatment-seeking behaviour for, CPPD, its preva-
lence does not appear to be a cultural factor [11–14].
Complementary and alternative medicine (CAM) in-
cludes a range of diverse health-related strategies that
can be described as predominantly operating outside the
conventional medical curriculum and medical profession
[15]. The prevalence of CAM use worldwide is substan-
tial [16, 17], especially amongst women [18–22]. There
is an acceptance of a multi-factorial aetiology for CPPD
[2, 4, 23] and to-date conventional treatment protocols,
which focus on symptom-relief, ranging from counsel-
ling to pharmaceutical to surgical, have been employed.
Neither single nor combinations of conventional therap-
ies have produced consistent positive outcomes for
CPPD [5] and a large variety of both conventional and
CAM approaches have been promoted by medical prac-
titioners [5, 24]. Indeed there are clinical trials that sup-
port the use of CAM for aspects of CPPD such as Vitex
agnus-castus [25] or Chinese herbs [26] for PMS and
Transcutaneous Electrical Nerve Stimulation (TENS)
[27] or acupuncture [28] for dysmenorrhoea. Previous
work exploring CAM use for CPPD symptoms has revealed
prevalence rates between 3 and 70 % [12, 13, 29–44]. al-
though prevalence of women’s CAM use at any point for
CPPD is likely to be very much higher [45–47]. Unfortu-
nately, the extent of this behaviour is unknown, particularly
in Western countries as few recent studies have been
undertaken. In addition there is a lack of good quality stud-
ies published in the peer-reviewed literature and surveys
have varied widely in sample size and source, baseline and
timeframe for measurement, questionnaire quality and
method of data collection. All health practitioners need to
be better-informed about this usage to enable more effect-
ive and safer symptom management.
Therefore, in an attempt to fill this gap in knowledge
regarding CAM use for CPPD, this study presents a de-
tailed analysis of the prevalence of CPPD symptoms in
women from the large, nationally-representative Austra-
lian Longitudinal Study on Women’s Health (ALSWH),
examining the specific CAM adopted by women, over a
twelve month timeframe, according to their symptoms.
Method
Sample
Data was obtained from the (born in) 1973–78 cohort of
the Australian Longitudinal Study on Women’s Health
(ALSWH). In 1996, the ALSWH participants were ran-
domly selected from the national Medicare database,
which is the universal healthcare provision for all Aus-
tralians. The recruited sample comprised over 58,000
women from 3 aged groups (ie. ‘young’: 18–23 years;
‘mid age’: 45–50 years; ‘older’: 70–75 years), to examine
women in the key stages of the lifespan. The recruited
women have been surveyed, via postal questionnaires, at
regular 3-yearly intervals. The ALSWH was designed to
follow the cohorts over 20 years to monitor changes in
health and are intended to help guide national health
policy and provision. The analyses presented in this
study were restricted to Survey 6 (conducted in 2012) of
the young cohort (when they were aged 34–39 years),
which included 8009 respondents, a retention rate of eli-
gible participants for this survey of 61.6 %. In the first
survey 14,247 women in this age group participated,
census data for this demographic at the time of recruit-
ment was 759,680. Ethical approval for the ALSWH was
gained from the Human Ethics Committees at the Uni-
versity of Queensland and University of Newcastle. The
study participants provided written consent.
Cyclic perimenstrual pain and discomfort symptoms
Women were asked if they had been diagnosed with
endometriosis in the last 3 years. In addition, they were
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also asked how frequently they experienced premen-
strual tension, irregular periods, heavy periods and se-
vere period pain in the previous 12 months, with the
response option being ‘never’, ‘rarely’, ‘sometimes’ or
‘often’.
Complementary and alternative medicine use
Women’s consultations with CAM practitioners were
ascertained by questionnaire items asking them is they
had consulted any of a list of practitioners, for their own
health, in the previous 12 months. The list of CAM
practitioners included: chiropractor, osteopath, massage
therapist, acupuncturist, naturopath/herbalist, and ‘an-
other alternative’ health practitioner.
Women’s use of CAM practices or products was ascer-
tained by questionnaire items asking them how fre-
quently they had used any of a list of therapies or
products, for their own health, in the previous
12 months. The list of therapies or products included:
vitamins/minerals, yoga/meditation, herbal medicines,
aromatherapy oils, Chinese medicine and ‘other alterna-
tive practices or products’. Possible response options
were ‘never’, ‘rarely’, ‘sometimes’ and ‘often’. Those
responding ‘never’ or ‘rarely’ were categorised as non-
users and the ‘sometimes’ and ‘often’ responders were
classified as users for analysis purposes.
Confounders
Potential confounders identified (that were available in
the questionnaire) were the demographic factors area of
residence, educational status, ability to manage on in-
come and marital status and the co-morbidities of
insulin-dependent (Type 1) diabetes, non-insulin
dependent (Type 2) diabetes, low iron (iron deficiency
or anaemia), depression, anxiety disorder, asthma, ‘other
cancer’ and hypertension.
Area of residence was categorised as either urban
or rural. Educational status was grouped as one of
three categories: no formal qualifications, year 10 or
equivalent (eg. school certificate), year 12 or equivalent
(e.g. higher school certificate); trade/apprenticeship or cer-
tificate/diploma; and university degree. Ability to manage
on available income was also grouped as one of three cat-
egories: it is impossible or it is difficult all of the time; it is
difficult some of the time; and it is not too bad or it is
easy. Marital status was grouped into three categories:
never married; married/de facto; and separated or di-
vorced or widowed.
Statistical analysis
Bivariate analyses testing the association between CPPD
symptom and CAM practitioner or CAM therapy use
was conducted using chi-square tests. Logistic regression
models were used to determine magnitude of association
between CPPD symptom and CAM practitioner or ther-
apy use, with adjustment for confounding variables. Stat-
istical significance was set at the α = 0.05 level for all
analyses, using the statistical package STATA 14.0.
Results
There were 7427 women who indicated they had not
had a bilateral oophorectomy and were either not preg-
nant or unsure if they were pregnant. Amongst these
women, the prevalence of CPPD-related problems was
3.7 % for endometriosis, 41.2 % had suffered from PMS
sometimes or often, 22.2 % had had irregular periods
sometimes or often, 29.8 % had experienced heavy pe-
riods sometimes or often and 24.1 % had had severe
period pain sometimes or often. Those women with
endometriosis may account for around 4.9 % of more
frequent (ie. sometimes/often) PMS sufferers, 6.1 % of
more frequent cases of irregular periods, 6.1 % of more
frequent heavy periods and 8.3 % of more frequent se-
vere period pain sufferers.
The association between CAM practitioner consulta-
tions and CPPD symptoms are presented in Table 1.
Women with endometriosis were significantly more
likely to consult with a massage therapist, acupuncturist,
and/or naturopath/herbalist compared to women who
did not have endometriosis (all p < 0.05). Consultations
with a naturopath/herbalist were significantly higher for
women suffering with irregular or heavy periods, com-
pared to those without irregular and/or heavy periods
(all p < 0.05). Similarly, women with severe period pain
were significantly more likely to consult with an acu-
puncturist and/or a naturopath/herbalist, compared to
women without severe period pain (all p < 0.05). Com-
pared to women without PMS, women with PMS were
significantly more likely to consult with a massage ther-
apist, acupuncturist, naturopath/herbalist and ‘other al-
ternative health practitioner’ (all p < 0.05).
Table 2 shows associations between use of CAM prac-
tices/products and CPPD symptoms. Women with PMS
and/or painful periods were significantly more likely to
use all CAM practices/products frequently, compared to
women without PMS and/or painful periods (all p < 0.05).
With the exception of aromatherapy oils, endometriosis
sufferers were significantly more likely to use all other
CAM practices/products, compared to women without
endometriosis (all p < 0.05). Women who were suffering
with irregular periods were more likely to use vitamins/
minerals, herbal medicines, Chinese medicines, and/or
‘other alternative practices and products’, compared to
women who did not suffer with irregular periods (all p
< 0.05). Women with menorrhagia were significantly
more likely to use herbal medicines, aromatherapy oils
and/or ‘other alternative practices and products’ com-
pared to non-sufferers (all p < 0.05).
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Astatistically significant association with chiropractor
Bstatistically significant association with osteopath
Cstatistically significant association with massage therapist
Dstatistically significant association with acupuncturist
Estatistically significant association with naturopath/herbalist











































































































































































































































































































Astatistically significant association with vitamins/minerals D statistically significant association with aromatherapy oils
Bstatistically significant association with yoga or meditation E statistically significant association Chinese medicines


















Logistic regression modelling was used to determine
the magnitude of associations between CPPD related
problems and consultations with CAM practitioners,
after adjusting for confounders (Table 3). Endometriosis
sufferers were nearly 50 % more likely to have consulted
a massage therapist (OR = 1.48; 95 % CI: 1.14, 1.92) and
nearly twice as likely to have consulted with an acupunc-
turist (OR = 1.79; 95 % CI: 1.26, 2.56), compared to
women without endometriosis. Women who ‘some-
times’ suffered PMS were more likely to have visited
with a massage therapist (OR = 1.29; 95 % CI: 1.12,
1.48) but for ‘often’ sufferers this association was
higher (OR = 1.47, 95 % CI: 1.23, 1.76), whilst ‘some-
times’ sufferers were also more likely to visit a na-
turopath/herbalists (OR = 1.48, 95 % CI: 1.19, 1.85)
but were more than twice as likely to have done so
when the PMS occurred ‘often’ (OR = 2.12, 95 % CI:
1.62, 2.76). Those women who indicated PMS oc-
curred ‘often’ were over 60 % more likely to have had
osteopathic treatment (OR = 1.64, 95 % CI: 1.19, 2.20),
and/or visited ‘another alternative health practitioner’
(OR = 1.66, 95 % CI: 1.20–2.29). Women who experi-
enced heavy periods ‘often’ were 30 % (OR = 0.70,
95 % CI: 0.56, 0.87) less likely to have used a massage
therapist. No statistically significant associations were
observed between any of the CAM practitioner
groups and irregular periods or painful periods.
Table 4 shows the results of logistic regression model-
ling used to determine the magnitude of associations be-
tween CPPD related problems and use of CAM
practices/products, after adjusting for confounders.
Women with endometriosis were more likely to have
used vitamins/minerals (OR = 1.72; 95 % CI: 1.24, 2.38),
yoga/meditation (OR = 1.80; 95 % CI: 1.37, 2.38) and/or
Chinese medicines (OR = 1.86; 95 % CI: 1.22, 2.83), com-
pared to women without endometriosis. PMS sufferers
showed around a 30 % (OR = 1.31; 95 % CI: 1.09, 1.56)
increased likelihood to have used herbal medicine if
their symptoms were ‘rare’ but this likelihood increased
for ‘sometimes’ sufferers (OR = 1.49; 95 % CI: 1.25, 1.77)























































































































































Astatistically significant association with chiropractor
Bstatistically significant association with osteopath
Cstatistically significant association with massage therapist
Dstatistically significant association with acupuncturist
Estatistically significant association with naturopath/herbalist
Fstatistically significant association with ‘other CAM’ practitioner
Adjusted for confounding variables - marital status, area of residence, educational status, low iron, depression and anxiety disorder
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and was greatest for ‘often’ sufferers (OR = 1.72; 95 % CI:
1.39, 2.14). Those who suffered PMS ‘sometimes’ or
‘often’ were also more likely to use vitamins/minerals
(OR = 1.31; 95 % CI: 1.13, 1.52 and OR = 1.47; 95 % CI:
1.21, 1.80 respectively), yoga/meditation (OR = 1.34;
95 % CI: 1.14, 1.59 and OR = 1.64; 95 % CI: 1.33, 2.02 re-
spectively), aromatherapy oils (OR = 1.49; 95 % CI: 1.23,
1.80 and OR = 1.53; 95 % CI: 1.21, 1.94 respectively)
and/or ‘other alternative therapies’ (OR = 1.46; 95 % CI:
1.16, 1.84 and OR = 1.69; 95 % CI: 1.27, 2.23 respect-
ively). Women who experienced heavy periods ‘often’
were less likely to use yoga/meditation (OR = 0.68; 95 %
CI: 0.53, 0.88), compared to women who ‘never’ experi-
enced heavy periods. Women who ‘sometimes’ had se-
vere period pain were more likely to have used
aromatherapy oils (OR = 1.46; 95 % CI: 1.17, 1.82) but if
the dysmenorrhoea was ‘often’ this likely use increased
to over 70 % (OR = 1.76; 95 % CI: 1.30, 2.38). This group
of ‘often ‘dysmenorrhoea sufferers were also more
likely to have used herbal medicines (OR = 1.63; 95 %
CI: 1.24, 2.15) and/or ‘other alternative therapies’
(OR = 1.73; 95 % CI: 1.21, 2.47), compared to women
who ‘never’ experienced dysmenorrhoea. There were no
significant associations between the irregular period cat-
egories and use of any CAM therapies or products.
Discussion
Results from this analysis of 34–39 year old menstruat-
ing women derived from a large nationally representative
sample of Australian women contributes important in-
formation regarding the prevalence of CPPD symptoms
and their relationship to the differential adoption of
CAM. The analysis further indicates that women experi-
encing CPPD symptoms are likely to be using CAM of
which the majority involves CAM products and therap-
ies rather than consultations with CAM practitioners.
Prevalence of CPPD
The prevalence for endometriosis in this cohort was
3.7 %, which is supported by the Global Burden of Dis-
ease Study 2013 which estimated the prevalence of
endometriosis at 4.8 % for the years 2006–13 [48].
The prevalence for PMS of 43.3 % in our study com-
pares favourably with that from international data of
Table 4 The odds ratio for association between cyclic perimenstrual pain and discomfort and use of complementary and alternative























































































































































Astatistically significant association with vitamins/minerals
Bstatistically significant association with yoga or meditation E statistically significant association Chinese medicines
Cstatistically significant association with herbal medicines F statistically significant association with ‘other alternative therapies’
Dstatistically significant association with aromatherapy oils
Adjusted for confounding variables - marital status, area of residence, educational status, low iron, depression and anxiety disorder
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47.8 % from a meta-analysis based on 17 international
studies from 1996 to 2011 [49]. Irregular periods were
experienced by 22.3 % of women in our cohort. A broad
range of prevalence estimates of irregular periods 6.5–
83.3 % was reported from a systematic review of data
from developing countries [50] and 25.6 % of 18–40
year-old nulliparous Danish women self-reported irregu-
lar periods [51]. Our cohort had a menorrhagia preva-
lence of 29.9 % which tallies well with self-reported
assessments elsewhere; a review of the literature up to
2005 found six reports of prevalence of heavy periods of
between 10 and 30 % with lower levels objectively deter-
mined while higher levels were based upon subjective
assessments [52]. The prevalence of severe period pain
determined from our data, at 24.2 %, falls within the
range derived from a 2002 to 2011 review across 15
studies of 2–29 % severe period pain [9]. Comparative
data for the same age group is limited, but includes
Korean [35], Japanese [29] and UK [53] surveys where
the prevalence was 68, 29.2 and 15 % respectively how-
ever only the latter two were based on severe levels of
dysmenorrhoea.
CAM use for CPPD
After adjusting for potential confounders, women with
endometriosis in our sample were much more likely to
visit with a massage therapist and/or acupuncturist and
to use vitamins/minerals, yoga/meditation and/or Chin-
ese medicines. Massage and acupuncture has previously
been reported by endometriosis sufferers as satisfactory
treatment for its associated leg pain [41] and there is
evidence that Chinese medicines and acupuncture can
reduce both endometriosis signs and symptoms. [54]
Whilst no other direct research has been carried out into
CAM for endometriosis there are studies indicating vita-
mins/minerals for reducing dysmenorrhoea which is a
significant factor in symptomatic endometriosis [55].
Our analyses indicate that frequent PMS sufferers are
more likely than those women who never or rarely ex-
perience this symptom to visit with a massage therapist
or naturopath/herbalist, as well as increasing the likeli-
hood of visiting an osteopath. All CAM practices and
products included in this study were used with a signifi-
cantly greater likelihood by women with PMS than those
who either did not, or rarely experienced PMS, except
for Chinese medicines and that there was an increasing
trend to use herbal medicine with increasing frequency
of PMS. PMS is the most common CPPD symptom in
our cohort and lack of specific, effective medications
may account for the higher observed likelihood of use of
multiple CAM practitioners and therapies. As reported
in previous studies, more than half of PMS sufferers
who used vitamins/dietary supplements [46, 56, 57], acu-
puncture [46, 58], homeopathy [46, 59], yoga/mind body
[57, 59] and massage [56, 57] have reported finding them
satisfactory as a treatment. The association between
CAM practitioner visits in our study provides some of
the only data available with regard to PMS sufferers. A
review of evidence for CAM and PMS highlighted at
least a 50 % improvement in symptoms from studies of
women using either acupuncture or herbal medicine
(both Western and Chinese) [60]. This is in contrast to
our data which found no association between more fre-
quent levels of PMS and visits to an acupuncturist or
use of Chinese medicines and this may reflect the cul-
tural differences in behaviour of Australian women with
less exposure and knowledge of traditional Chinese
medicine than women in cultures where it is more main
stream. Systematic reviews of PMS treatment have indi-
cated CAM that may be useful includes massage ther-
apy, reflexology, calcium, vitamin B6 [61, 62] and
possibly magnesium and yoga [62]. Our data indicates
that women with PMS are indeed adopting these CAM.
Irregular and heavy periods and CAM use has not
been well investigated, although there are qualitative
studies showing that either type of irregular bleeding has
been given as a reason for seeking out CAM [34, 58, 63].
However, analysis of specific CAM use is scant, with use
of these modalities being based on tradition or anecdotal
evidence. Those women in our study were no more
likely to use any CAM practitioner or CAM practice/
product compared to non-sufferers. However women
with heavy periods demonstrated a decreased likelihood
of visiting a massage therapist or using yoga/meditation.
Menorrhagia is likely to limit women’s daily activities
due to discomfort and embarrassment and therefore
these results are not unexpected [64].
Women with severe period pain in this cohort used
limited CAM, being more likely to have used aromather-
apy oils when dysmenorrhoea occurred with any sort of
frequency and herbal medicines if the pain occurred
often. There are a number of surveys into women’s
choice of treatment for dysmenorrhoea and they have
reported that over 50 % of women surveyed were sat-
isfied with herbal medicine [32, 42, 58], vitamin/diet-
ary supplements [32, 58] and acupuncture for ‘pelvic
discomfort’ [58] however the latter two CAM were
not significantly adopted by our cohort. A few recent
clinical trials indicated aromatherapy may reduce dys-
menorrhoea [65, 66] and traditional herbal medicines
have established uterine spasmolytic properties and
have also been effective in trials in reducing dysmen-
orrhoea [67, 68] lending support to the practice
highlighted in our analysis.
For many women, both the regular occurrence of
CPPD symptoms and lack of effective treatments of-
fered, may explain sufferers frequent adoption of some
CAM. That CAM practitioner visits are much less
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prevalent than CAM practice/product use leads to the
conclusion that self-prescription in this sector is com-
mon and raises important issues of efficacy and safety in
the absence of professional supervision. In addition,
whilst CPPD categories have been largely compartmen-
talised in the literature, data from this survey indicates a
great deal of crossover of CPPD symptoms within this
age group. The overall prevalence of CPPD is 56.8 % in
this cohort emphasising the significance of CPPD as a
health issue amongst women aged 34 – 39 years and in-
deed this level is likely to be understated as only severe
levels of dysmenorrhoea were recorded.
The limitations of our study are first the retrospective
recording of both CAM use and CPPD symptoms which
are therefore subject to recall bias. Second, due to the
self-perceived nature of the CPPD symptoms examined
and the lack of a clear definition to categorise them, sub-
jective reporting makes data comparisons more difficult.
The large sample size and otherwise representative na-
ture of this cohort of 34–39 year old women, as well as
the specific enquiry into those CAM commonly used in
Australia does however provide valuable insights, espe-
cially for health providers, into the extent and preferen-
tial use of CAM for specific CPPD symptoms.
Conclusion
This analysis has confirmed the high levels of CPPD
symptoms and CAM use amongst women in this age
group and provides the first detailed insight into the dif-
ferential adoption of different individual CAM practi-
tioners and practices/products across CPPD symptoms.
Whilst women with PMS and severe dysmenorrhoea are
using CAM, those with heavy and irregular bleeding
may be unaware of existing CAM options. However,
more extensive investigation is required to ascertain how
effective and safe CAM use is in these circumstances,
what is motivating their usage and how well informed all
relevant health practitioners, as well as women with
CPPD, are regarding the use of appropriate CAM.
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